Pharmaceutical Technology Europe
While most companies recognise the significance of emerging markets, they struggle to jump the first hurdle in addressing these opportunities: defining the right product.
Much has been written about the importance of emerging markets for driving future growth, but while most companies recognise their significance, they struggle to jump the first hurdle in addressing these opportunities: defining the right product. Many mistakes arise from the single misconception that emerging markets are all broadly the same and that you can tackle them with a single common strategy.
C.O.T/a.collectionRF/Getty Images
But you can't. To avoid this mistake as you develop your product strategy, keep in mind some common pitfalls:
Do you believe that a single corporate strategy is sufficient for the fragmented nature of the emerging markets? Source: www.pharmtech.com poll, conducted June-July 2011.These are just a few of the considerations that companies should take into account when entering these markets. Regardless of your approach, it's worth getting it "right" because it could be one of the keys to sustainable growth.
Cole Shelton is an innovation and technology management consultant at Sagentia Ltd.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.